Abstract
Recent evidence suggests an intriguing link between p53 and the Fas pathway. To evaluate this association further, we utilized a recombinant adenoviral vector (AdWTp53) to overexpress wild-type p53 in lung cancer (A549, H23, EKVX and HOP92) and breast cancer (MDA-MB-231 and MCF-7) cell lines and observed an increase in the Fas/CD95/APO-1 protein levels. Furthermore, this increase correlated with the sensitivity of the cell lines to p53-mediated cytotoxicity. To examine the effects of Fas over-expression in cells resistant to p53 over-expression, we constructed AdFas, an adenoviral vector capable of transferring functional human Fas to cancer cells. Interestingly, infection of p53-resistant MCF-7 cells with AdFas sensitized them to p53-mediated apoptosis. These studies indicate that combined over-expression of Fas and wild-type p53 may be an effective cancer gene therapy approach, especially in cells relatively resistant to p53 over-expression.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by M. Israel
Rights and permissions
About this article
Cite this article
Rakkar, A., Katayose, Y., Kim, M. et al. A novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosis. Cell Death Differ 6, 326–333 (1999). https://doi.org/10.1038/sj.cdd.4400498
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400498
Keywords
This article is cited by
-
Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas
British Journal of Cancer (2002)
-
Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer
Oncogene (2001)
-
Shared pathways: Death receptors and cytotoxic drugs in cancer therapy
Pathology & Oncology Research (2001)
-
Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy
Breast Cancer Research (1999)